Recommendations around dosing, duration, and patient-specific options are woven into the fabric of the scientific statement.

The American College of Cardiology issued a 2026 scientific statement on direct oral anticoagulants for the prevention of thrombotic events.

For adults who have survived a heart attack or stroke, taking aspirin regularly may reduce the risk of another cardiovascular event. But a new study suggests that less than half of these ...

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...

A new editorial in JAMA Cardiology has rekindled discussions about the role of aspirin for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD) and whether there’s a ...

In recognition of the importance of secondary prevention, the World Heart Federation has produced an extensive report that examines take-up of secondary prevention measures across leading countries.

A recent presentation at the Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting in Washington, DC, by Dr Anthony Bavry (University of Florida) was titled "Aspirin: the Most Understood and ...

Both aspirin and clopidogrel reduce the rate of cardiovascular events in patients with coronary heart disease. We estimated the cost effectiveness of the increased use of aspirin, clopidogrel, or both ...

Ischemic heart disease and stroke are the leading causes of death worldwide. A large proportion of individuals at high 10-year risk of a cardiovascular event live in low-income and middle-income ...